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In a screen for proteins that interact with Jak2, we identified a previously uncharacterized 70-kDa protein
and cloned the corresponding cDNA. The predicated sequence indicates that p70 contains an SH3 domain and
a C-terminal domain with similarities to the catalytic motif of phosphoglycerate mutase. p70 transcripts were
found in all tissues examined. Similarly, when an antibody raised against a C-terminal peptide to analyze p70
protein expression was used, all murine tissues examined were found to express p70. To investigate the in vivo
role of p70, we generated a p70-deficient mouse strain. Mice lacking p70 are viable, develop normally, and do
not display any obvious abnormalities. No differences were detected in various hematological parameters,
including bone marrow colony-forming ability, in response to cytokines that utilize Jak2. In addition, no
impairment in B- and T-cell development and proliferative ability was detected.
A variety of cytokine receptors recruit and mediate the ac-
tivation of Jak2, including the receptor for erythropoietin
(Epo) (7, 13). The essential role that Jak2 plays in the function
of these receptor complexes is illustrated by the loss of their
function in Jak2-deficient cells (15, 16). The activation of Jak2
results in the tyrosine phosphorylation of multiple sites on the
receptor chains and the subsequent recruitment of a variety of
proteins to the receptor complex (5, 20, 24). The proteins
recruited to the receptor complex are hypothesized to be crit-
ical for the subsequent cellular responses (see, for example,
reference 4). However, in the case of the receptor for Epo,
mice have been derived in which the distal half of the receptor
cytoplasmic domain has been deleted and in which the single
remaining tyrosine has been mutated to a phenylalanine (27).
Remarkably, these mice are relatively normal, and, specifically,
the Epo receptor retains its ability to support erythroid lineage
expansion and differentiation. In the absence of evidence that
receptor tyrosines are required for recruitment of essential
signaling proteins to the receptor complex, we have focused on
the possibility that sites of tyrosine phosphorylation on Jak2
may play essential roles in recruiting signaling proteins (10, 21,
27).
The activation of Jak2 initially requires transphosphoryla-
tion of a critical tyrosine in the activation loop, Y1007, compa-
rable to most tyrosine kinases (6). Following activation of ki-
nase activity, there are a number of additional tyrosine
residues that are phosphorylated. One of the major sites of
autophosphorylation within murine Jak2 is Y966 (T. Matsuda
and J. N. Ihle, unpublished data). In assessing the potential
role for this site, we initially sought to determine which of the
known signaling proteins would bind to the site by affinity
isolation. Strikingly, a number of proteins known to be in-
volved in signal transduction bound a tyrosine-phosphorylated
peptide derived from the amino acid sequence surrounding
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FIG. 1. Peptide pulldown assay with Jak2-derived peptides. Cells
were starved of growth factor overnight and were either left untreated
() or treated with IL-3 for 5 min (). Lysates were prepared and
incubated with Sepharose beads to which nonphosphorylated Y966
peptide (TSQICKGMEYLGTKR) or tyrosine phosphorylated pY966
peptide (TSQICKGMEpYLGTKR) was conjugated, as outlined in
Materials and Methods. Bound proteins were separated by SDS-
PAGE, and tyrosine-phosphorylated proteins were analyzed by West-
ern blotting with antiphosphotyrosine antibodies.
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Jak2 Y966. Among these proteins were phospholipase (PLC)-
1, PLC-2, the phosphatidylinositol (PI) 3-kinase adapter
subunits p85 and p85, the PI 3-kinase catalytic subunit
p110, SHC, and Stat5a and -b. The binding was unique to
Jak2-Y966 among the phosphorylation sites examined and spe-
cifically required the phosphorylation of Y966. Because of the
unique properties of Y966, we used a large-scale affinity puri-
fication approach to identify novel proteins that would be re-
cruited into complexes at this site and identified a novel pro-
tein of 70 kDa. Here we report the properties of p70,
demonstrate that mice lacking p70 are not detectably altered
relative to wild-type mice, and show that p70 is not required for
the responses of cytokines that utilize Jak2.
MATERIALS AND METHODS
Peptide pulldown assay. DA3 cells (11) growing in media containing 10% fetal
calf serum (FCS) (HyClone) and 5 ng of interleukin 3 (IL-3)/ml were washed
twice with phosphate-buffered saline (PBS) and were incubated overnight in
media containing 0.5% FCS. Unstimulated cells or cells treated for 10 min with
50 ng of IL-3/ml (106/assay) were lysed in buffer containing 50 mM Tris, pH 8.0,
50 mM NaCl, 5 mM EDTA, 1 mM EGTA, 1% Triton X-100, 0.5 g of leupeptin/
ml, 0.1 g of aprotinin/ml, 100 g of phenylmethylsulfonyl fluoride (PMSF)/ml,
and 1 mM Na3VO4. Following removal of the nuclei by centrifugation at 10,000
 g, cytoplasmic lysates were incubated with 20 l of Sepharose beads that had
been conjugated by glutaraldehyde either with the peptide TSQICKGMEYLG
TKR or the peptide TSQICKGMEpYLGTKR. The beads were incubated with
the cytoplasmic lysates for 20 min at 4°C, washed five times with buffer containing
20 mM Tris, pH 7.8, 150 mM NaCl, 1 mM EDTA, 0.1% Triton X-100, 100 M
PMSF, and 1 mM Na3VO4. Bound proteins were eluted with Laemmli sample
FIG. 2. The p70 gene. (A) Nucleotide sequence and predicted amino acid sequence of p70 open reading frame. Underlined amino acids indicate
peptides obtained from microsequencing-purified p70 protein, as described in Materials and Methods. (B) Alignment of C-terminal region of p70 with
a consensus sequence built by the Protein Family (Pfam) database for members of the phosphoglycerate mutase family (1). The two arginines, two
histidines, and glutamic acid predicted to be involved in catalytic activity are highlighted. Identical residues are indicated with two dots; chemically similar
residues are indicated with one dot. (C) Peptide competition analysis. Proteins precipitated from lysates of DA3 cells by anti-p70 peptide antibody were
separated by SDS-PAGE and transferred to nitrocellulose. The membrane was probed with anti-p70 peptide antibody. Prior to immunoprecipitation,
lysates were incubated for 15 min with the following: lane 1, no peptide; lane 2, antigenic peptide; and lane 3, unrelated peptide. Number of kilodaltons
is given on right. (D) Interaction of p70 with phosphorylated Jak2 Y966 peptide. DA3 cytoplasmic lysates were subjected to immunoprecipitation with
anti-p70 peptide antibodies (lane 1) or affinity pulldown assays utilizing nonphosphorylated Y966 peptide conjugated to Sepharose (lane 2) or phosphor-
ylated Y966 peptide conjugated to Sepharose (lane 3). Blotting antibody was anti-p70 peptide antibody.
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buffer, resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE), and visualized by Western blot analysis as described below.
Isolation of p70 protein. Fifty liters of DA3 cells was grown to a confluence of
2  106 cells/ml in RPMI medium (Gibco-Life Technologies) containing 10%
FCS and 5 ng of IL-3/ml. Following two washes in PBS to remove growth factor,
cells were cultured overnight in RPMI medium containing 1% FCS, pelleted,
and lysed in ice-cold lysis buffer (see above). Nuclei were removed by centrifu-
gation at 10,000  g. Approximately 100 ml (15 mg/ml) of lysate was applied to
a Q-Sepharose column (2.5 by 10 cm) previously equilibrated in ice-cold buffer
containing 50 mM Tris, pH 8.0, 50 mM NaCl, 5 mM EDTA, 100 g of PMSF/ml,
and 1 mM Na3VO4. The column was washed extensively in lysis buffer, and
bound proteins were step eluted with lysis buffer containing 150 mM NaCl. The
eluate was passed sequentially over a Sepharose column to which had been
conjugated the peptide TSQICKGMEYLGTKR (1 by 2 cm), and a Sepharose
column to which had been conjugated the tyrosine-phosphorylated peptide
TSQICKGMEpYLGTKR (1 by 1 cm). The latter column was washed extensively
with load buffer and distilled water, and bound proteins were eluted with 2%
acetic acid. Following removal of the solvent by lyophilization, the eluted mate-
rial was suspended in Laemmli sample buffer, resolved by SDS-PAGE, and
detected by Coomassie blue staining. The protein band representing p70 was
extracted from the polyacrylamide gel, and the peptide sequence of p70 protein
was obtained as described earlier (23).
Cloning of p70 cDNA. The peptides obtained from microsequencing p70 were
used to screen a database of expressed sequence tags (ESTs), identifying an EST
that coded for three of the five peptides (GenBank accession no. AA190028).
The EST fragment was used as a probe to screen a randomly primed mouse brain
cDNA library (Stratagene). Positive clones (4) representing partial fragments of
p70 cDNA were isolated in a screen of 7.5  105 individual clones conducted
according to standard techniques, and cDNA inserts were subcloned into pBlue-
script and subjected to sequence analysis. Overlapping cDNA fragments were
pieced together to generate a full-length cDNA.
Rabbit polyclonal antibodies. A peptide corresponding to the predicted C
terminus of p70 (CPTGGFNWRETLLQE) was synthesized, conjugated to glu-
taraldehyde-activated keyhole limpet hemocyanin, and used to immunize two
rabbits (Rockland). Before use, antibodies were purified by affinity chromatog-
raphy over a peptide column.
Transfections, immunoprecipitations and Western blots. COS7 cell transfec-
tions were performed with Polyfect (Qiagen) according to the manufacturer’s
instructions. Cell lysates were made by lysing cells in ice-cold lysis buffer (see
above), clarified by centrifugation, rotated at 4°C with specific antibody for 2 h,
and incubated 1 h with 20 l of protein A Sepharose. Beads were washed five
times with cold wash buffer (20 mM Tris, pH 7.8, 150 mM NaCl, 1 mM EDTA,
0.1% Triton X-100, 100 M PMSF, and 1 mM Na3VO4), and bound protein was
eluted with Laemmli sample buffer and separated by SDS-PAGE. Protein was
transferred to nitrocellulose using a semidry transfer apparatus (Bio-Rad),
blocked with 3% bovine serum albumin in TBST (10 mM Tris [pH 8.0], 150 mM
NaCl, 0.1% Tween 20), incubated at 23°C for 1 h with specific antibody, washed
with TBST, incubated for 1 h with horseradish peroxidase-conjugated secondary
antibody (Amersham), and developed according to the manufacturer’s instruc-
tions.
Generation of p70-deficient mice. p70 genomic clones were isolated from a
W9.5 embryonic stem cell BAC library (Incyte Genomics, St. Louis, Mo.) by
screening with [-32P]dCTP-labeled EST no. AA198028 as a probe. A restriction
enzyme map of the p70 locus was determined using BAC clones and murine
genomic DNA. A 10-kb fragment of p70 genomic sequence containing two exons
encoding amino acid residues 9 to 88 was subcloned into pBluescript. A 2.2-kb
SphI fragment containing the two exons was replaced with a cDNA encoding the
neomycin resistance gene driven by the thymidine kinase promoter oriented in
the direction opposite to that of p70 transcription. A cDNA encoding the diph-
theria toxin gene driven by the thymidine kinase promoter (25) to be used in
negative selection was then placed 3	 of the p70 homology region to complete the
targeting construct. p70-deficient mice were generated essentially as previously
described (22). Briefly, 129/SvJ E14 ES cells were electroporated with 20 g of
SalI-linearized targeting vector and selected with 350 g of Geneticin (Gibco-
BRL)/ml. Four hundred fifty G418-resistant clones were isolated, expanded, and
analyzed by Southern analysis for correct integration of the mutation, by probing
with a BamHI genomic fragment 3	 to the region of homology within the tar-
geting construct. Five clones heterozygous for the induced mutation were in-
FIG. 2—Continued.
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jected into C57BL/6 blastocyts, which were then implanted into pseudopregnant
females. Male chimeras from three clones successfully passed the induced mu-
tation through the germ line. Heterozygote agouti mice were interbred to pro-
duce wild-type and p70-deficient littermates on a mixed 129/SvJ/BL/6 back-
ground. Genotype was determined by PCR using the following primers: wild-type
allele, CGGTGAGTAAGAATCCGCTCAGTA and CACATGCTGCCTGAA
CGCTTCTT (300 bp); and knockout allele, CGGTGAGTAAGAATCCGCTC
AGTA and GCATCGCCTTCTATCGCCTTCTTG (150 bp). Animals were
housed under specific-pathogen-free conditions under institutional guidelines.
DNA and RNA analysis. Genomic DNA was isolated by lysing tissue in buffer
(100 mM Tris, pH 8.0, 5 mM EDTA, 0.2% SDS, 200 mM NaCl, and 250 g of
proteinase K/ml), incubating 12 h at 55°C, extracting with phenol-chloroform,
and precipitating with ethyl alcohol. After restriction enzyme digestion, DNA
was separated by agarose gel electrophoresis and transferred to positively
charged nylon (Amersham) for hybridization with labeled probes (Rediprime;
Amersham) according to standard techniques. RNA was prepared by extracting
tissue with Trizol according to the manufacturer’s instructions (Gibco BRL),
separated by formaldehyde gel electrophoresis, and analyzed as described above.
A Northern blot of murine poly(A) RNA (Clontech) was probed with a radio-
labeled fragment of p70 cDNA corresponding to nucleotides encoding amino
acid residues 469 to 501.
Histology. For organ histological analysis, tissues were fixed overnight in 10%
buffered formalin (Fisher Scientific). Fixed tissues were embedded in paraffin,
sectioned (10 m), and stained with hematoxylin and eosin.
FACS analysis and cell purification. Whole spleens, thymi, or lymph nodes
were dissected from littermates and crushed through a 70-m-pore-size nylon
mesh in PBS containing 2% FCS. Bone marrow was obtained by flushing femurs
and tibias with the same buffer. Red blood cells were lysed by addition of buffer
(pH 7.2) containing 150 mM NH4Cl, 1 mM KHCO3, and 0.1 mM EDTA; debris
was removed by straining; and cells were labeled with fluorescein isothiocyanate
(FITC)-conjugated antibodies as indicated. Routine fluorescence-activated cell
sorter (FACS) analysis was performed with a FACSCalibur (Becton Dickinson).
For proliferation assays, B and T cells were purified to 
98% purity by labeling
with FITC-conjugated Thy1.2 antibody (Pharmingen) and phycoerythrin (PE)-
conjugated B220 antibody (Pharmingen), and sorting with a MoFlo Cell Sorter
(Cytomation). In some instances, B cells were purified by complement-mediated
lysis utilizing anti-Thy1.2 monoclonal antibody and a mixture of guinea pig and
rabbit complement (Cederlane) according to the instructions of the manufac-
turer.
Proliferation assays. B or T cells (105) were placed in individual wells of a
round-bottomed 96-well plate in RPMI media containing 10% FCS, 10 mM
HEPES, pH 7.0, 2 mM glutamine, 1 mM sodium pyruvate (Gibco BRL), 50 M
-mercaptoethanol (Gibco BRL), 0.1 mM nonessential amino acids (Gibco
BRL), and 10 g of gentamicin (Gibco BRL)/ml. B-cell mitogens were at the
following concentrations: immunoglobulin M (IgM), 10 g/ml; IL-4, 100 ng/ml;
anti-CD40, 1 g/ml; and lipopolysaccharide, 10 g/ml. For T-cell proliferation
assays, a solution of 10 g of the indicated antibody/ml was used to coat the
bottom of each well by incubation at 37°C for 2 h. IL-2 at 25 ng/ml was included
where indicated. Each assay was conducted in triplicate, and the data presented
are representative of three individual experiments.
Blood cell counts and colony assays. To analyze peripheral blood, samples
were taken from the orbital sinus using heparinized microhematocrit capillary
tubes (Fisher). Twenty microliters was analyzed by a MASCOT Hemavet 3700R
counter (CDC Technologies), scoring for white blood cells and red blood cells.
Hematocrits were calculated by a Hemavet counter based on red blood cell
counts and mean corpuscular volume. To assay bone marrow progenitor colony-
forming ability, bone marrow was flushed as described above, cells were plated,
and colonies were scored as previously described (27).
RESULTS
Identification and cloning of p70. Jak2 is activated in the
context of a number of cytokine receptors (12). As a conse-
quence, it is tyrosine phosphorylated at 10 predominant sites
(Matsuda and Ihle, unpublished data). Among these sites, mu-
rine Jak2-Y966 was identified as a potentially important site
based on mutational analysis and on the ability of a phos-
phopeptide containing this site to bind a number of proteins
known to be involved in signal transduction. These proteins
include such molecules as Stat5a and -b, PLC-1, PLC-2, the
PI 3-kinase adapter subunits p85 and -, the PI 3-kinase
catalytic subunit p110, and SHC (Fig. 1). To identify novel
proteins that might be recruited to this site, a large-scale af-
finity column approach was used as detailed in Materials and
Methods and the affinity-purified proteins were sequenced.
Protein microsequencing of a 70-kDa protein identified five
peptides, three of which were found to be encoded in the
sequence of a cDNA for an uncharacterized EST (GenBank
accession no. AA190028). To clone the complete p70 cDNA,
one of the ESTs was used to isolate four overlapping cDNA
fragments from a murine library. The predicted protein from
the compiled cDNA sequences would contain 603 amino acids
with a calculated molecular mass of 67.5 kDa and included all
five peptides identified by microsequencing (Fig. 2A).
The protein sequence of p70 reveals two previously defined
protein domains. Residues 211 to 271 are predicted to contain
an SH3 domain, a domain that interacts with protein se-
quences containing prolines and hydrophobic residues (17, 26).
A second region in the carboxyl-terminal portion is 46% sim-
ilar to the catalytic domain motif found in members of the
bis-phosphogylcerate mutase family. Members of this family
are structurally related enzymes that catalyze the transfer of
phosphogroups from small molecules such as phosphoglycer-
ate and fructose-2,6-phosphate (1, 18). Modeling of the cata-
lytic domain of family members reveals a hydrophobic core
surrounding a constellation of active site residues (2, 9), in-
cluding two conserved histidines, two conserved arginines, and
a glutamic acid (14). Five residues of murine p70, Arg-344,
His-345, Arg-427, Glu-455, and His-530, are present in an
orientation consistent with the existence of an evolutionary
relationship between p70 and members of the bis-phosphoglyc-
erate mutase family (Fig. 2B).
Screening of databases resulted in the identification of both
human and Drosophila homologues of murine p70, and, im-
portantly, both genes contained the SH3 and potential catalytic
domain of the bis-phosphoglycerate mutase family.
Biological characterization of p70. To initially characterize
the biological functions of p70, an antiserum against a C-
terminal peptide sequence was generated. As illustrated (Fig.
2C), this antibody recognizes a protein of 70 kDa and this
recognition was blocked by the immunizing peptide but not by
an unrelated peptide. Moreover, this antiserum detected a
70-kDa protein that was specifically isolated by the Jak2 Y966
phosphopeptide affinity column and was not obtained from a
peptide affinity column that contained the nonphosphorylated
peptide (Fig. 2D). To further assess the ability of p70 to inter-
act with Jak2, COS7 cells were cotransfected with expression
vectors for Jak2 and a C-terminal Flag-tagged version of p70.
As illustrated in Fig. 3, p70 was readily detected in the immu-
FIG. 3. Coimmunoprecipitation of Jak2 and p70. Cos cells were
cotransfected as indicated, and lysates were subjected to immunopre-
cipitation (IP)/Western blot analysis with the indicated antibody.
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noprecipitates of Jak2. Conversely, immunoprecipitation of
p70 resulted in the coimmunoprecipitation of Jak2. However,
in spite of the readily detectable association of the two proteins
in cotransfection experiments, we have been unable to dem-
onstrate the coimmunoprecipitation of the endogenous pro-
teins under a variety of conditions resulting in the activation of
Jak2.
To begin to obtain insights into the potential biological func-
tion of p70, the pattern of expression of p70 was determined.
As illustrated in Fig. 4A, there are two transcripts of 4 and 6 kb
that contain p70 sequences. Both of these transcripts are larger
than the compiled cDNA sequence, suggesting that additional
5	 and/or 3	 untranslated regions exist. By Northern analysis,
p70 transcripts are present in a variety of tissues. Consistent
with this, a broad pattern of p70 protein expression was de-
tected in a variety of cell lines as well as various mouse tissues.
Derivation of p70-deficient mice. To explore the in vivo
function of the p70 gene, p70-deficient mice were generated by
gene targeting (3). Genomic p70 clones were isolated from a
W9.5 ES cell BAC genomic library, and four partially overlap-
ping clones were obtained. These clones did not contain the
most amino terminal residues of p70 but did contain an exon
encoding amino acid residues 9 to 26, designated as exon 2. As
indicated in Fig. 5A, a targeting vector was constructed that
would remove two coding exons (amino acids 9 to 88) and
replace them with a neomycin resistance gene. The targeting
vector was introduced into E14 ES cells, and five correctly
targeted, independent clones were obtained. Three indepen-
dent heterozygous ES cell lines were used to generate chimeric
mice that transmitted the mutated allele through the germ line.
Mice heterozygous for the induced mutation were interbred to
produce homozygous mutant mice. Transmission of the mu-
tated allele was confirmed by Southern analysis (Fig. 5B).
Northern analysis with a probe downstream of the deleted
exons was utilized to confirm the absence of p70 mRNA in
mice homozygous for the mutation (Fig. 5C). Finally, anti-p70
antibody was utilized to confirm the absence of p70 protein or
an amino-truncated protein in homozygous mice (Fig. 5D).
Analysis of p70-deficient mice. Interbreeding of p70 hetero-
zygote mice produced litters with the expected Mendelian ratio
of /, /, and / mice (1:2:1). At a gross level, p70-
deficient mice were indistinguishable from their wild-type and
p70 heterozygote littermates, developed normally, appeared
healthy, did not succumb to any unusual pathology, and sur-
vived with a comparable longevity. Similarly, male and female
p70/ mice did not display any defects in their reproductive
abilities. Histological examination of various organs revealed
no differences between wild-type and p70-deficient mice. In
addition, the architectures of the thymus, spleen, and lymph
nodes were indistinguishable from those in wild-type mice.
Blood serum chemistry (levels of albumin, alanine aminotrans-
ferase, amylase, bilirubin, creatinine, cholesterol, glucose,
globulin, and cations) was not significantly different from that
of wild-type mice. Additionally, wild-type and knockout mice
that were starved overnight and administered glucose dis-
played similar responses to intraperitoneal glucose tolerance
tests.
Because of the relatively high expression of p70 in hemato-
poietic tissues, various hematological parameters were exam-
ined. There were no significant differences between wild-type
and mutant mice in the number of red cells, hemoglobin levels,
or hematocrits. Similarly, there were no significant effects on
the numbers and morphology of peripheral blood leukocytes,
including neutrophils, eosinophils, basophils, monocytes, and
lymphocytes. The recovery of bone marrow cells was normal,
and in colony assays of bone marrow hematopoietic progeni-
tors, there were no significant alterations in the frequency and
morphology of colonies in response to a variety of cytokines
FIG. 4. p70 expression analysis. (A) Northern blots containing poly(A) RNA from multiple murine tissues were probed with a p70 cDNA
probe (upper panel) or a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe (lower panel). Positions of p70 mRNA and GAPDH
mRNA are indicated, as are positions of standard markers, in kilobases. (B) Lysates prepared from the indicated cell lines were subjected to
immunoprecipitation/Western blot analysis utilizing anti-p70 peptide antibody. (C) Lysates prepared from the indicated murine tissues were
subjected to immunoprecipitation/Western blot analysis utilizing anti-p70 peptide antibody.
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(Table 1). Importantly, the response to cytokines that are
known to require Jak2, including Epo and IL-3, was not de-
tectably affected by the absence of p70.
With regard to the lymphoid lineages, we observed normal
numbers of pro-B (IgM B220low, CD43, and CD25), pre-B
(IgM, B220, CD43, and CD25), and mature B (IgM,
B220, CD43, and CD25) cells in the bone marrow of
p70-deficient mice (data not shown) (8). Similarly, levels of
bone marrow CD117, Ter119, Gr1, and Mac1 cells were
normal in the knockout mice. Flow cytometry analysis of de-
veloping thymocytes revealed no difference in numbers and
proportions of double-negative (CD4 CD8), double-posi-
tive (CD4 CD8), and single-positive (CD4 CD8 or CD4
CD8) (Fig. 6A) cells, indicating that T-cell development is
unaffected by p70 deficiency. Peripheral T-cell numbers, as
measured by anti-Thy1.2 or anti-CD3 reactivity, were likewise
unaffected by the absence of p70, as were the levels and ratio
of CD4 or CD8 single-positive T cells (Fig. 6B). To assess
whether the deletion of p70 affected mature B-cell develop-
ment, we analyzed by flow cytometry B-cell populations in the
spleen and lymph nodes by using antibodies to B220, CD19,
IgM, and IgD. There was no significant difference in numbers
and maturation of peripheral B cells between / and /
mice (Fig. 6C). We then analyzed the proliferative ability of
peripheral lymphocytes when stimulated by different agents. B
and T cells were purified by FACS and were cultured in the
presence of various mitogenic agents. Figure 7 demonstrates
the absence of a significant difference between the ability of
wild-type and p70-deficient B and T cells to respond to differ-
ent stimuli.
DISCUSSION
The studies presented here are part of a general effort to
identify proteins that are recruited to cytokine receptor com-
plexes through the direct, or indirect, interaction with tyrosine-
phosphorylated Jak2. As illustrated, a novel 70-kDa protein
was identified that specifically binds to a peptide containing
one of the major sites of autophosphorylation of murine Jak2,
Tyr-966, and that coimmunoprecipitates with Jak2 in trans-
fected cells. The basis for the interaction with Jak2 has not
been precisely defined. In particular, although binding is spe-
cific for the phosphorylated peptide, binding occurs in the
absence of any known phosphotyrosine binding domains. It is
therefore likely that an adapter protein is involved in the bind-
ing. For example, a catalytic subunit of PI 3-kinase, p110, is
also isolated from the Y966 phosphopeptide affinity column
through its association with the PI 3-kinase adapter subunits
p85 and - (S.-T. Jou and Ihle, unpublished data). Studies are
in progress to assess the potential for p70 to interact with
several known adapter proteins.
As illustrated, interaction with Jak2 can also be shown to
FIG. 5. p70 targeting. (A) Structure of the p70 targeting construct. The two filled boxes represent putative exons 2 and 3. NheI (N), BamHI (B),
and SphI (S) sites are indicated, as is the location of the probe utilized in Southern analysis to distinguish wild-type and targeted alleles (black bar).
Neo, neomycin resistance cassette; DTA, diphtheria toxin cassette. (B) Southern blot of BamHI-digested genomic DNA from /, /, and /
mice probed with the external probe illustrated in Fig. 4A. Bands generated by the wild-type (/), heterozygote (/), and targeted (/) alleles
are indicated. WT, wild type; KO, knockout. (C) Northern analysis of RNA isolated from wild-type (/) or p70-deficient (/) thymi. The blot
was probed with a p70 cDNA probe that was 3	 to the targeted exons as indicated in Materials and Methods. The bottom panel indicates the 28S
and 18S RNAs as loading controls. (D) Immunoprecipitation (IP)/Western blot analysis of levels of p70 protein in splenic lysates prepared from
/ (WT), / (Het), and / (KO) littermates.
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occur in cells in which the two proteins are overexpressed.
However, numerous attempts to demonstrate coimmunopre-
cipitation of endogenous proteins under conditions of activa-
tion of Jak2 have failed. It is possible that the fraction of Jak2
activated in these situations, which would be limited by the
receptor numbers, is too low to allow detection of the proteins.
Alternatively, it is possible that overexpression gives rise to
associations that are not physiologically evident. Similarly, iso-
lation on affinity columns may be occurring at protein concen-
trations that are not present in a physiologically relevant re-
ceptor complex. In this regard it is important to note that,
although Stat5a and Stat5b bind specifically to the tyrosine-
phosphorylated mJak2-Y966 peptide, the recruitment and ac-
tivation of Stat5a and -b in the context of the Epo receptor
require specific receptor tyrosines (19). Since it was not possi-
ble to strictly rule in, or out, a role for p70 in Jak2 activity
based on these biochemical approaches, we also utilized a
genetic approach.
Beyond a potential role in signaling from cytokine receptors
utilizing Jak2, the properties of p70 provide few additional
clues regarding its physiological role. The gene is conserved, as
evidenced by the existence of homologues in other species.
However, in these species, p70 is similarly an uncharacterized
gene product of an EST and consequently nothing is known
regarding its function. The gene is widely expressed in mouse
tissues, which does not allow a focus for function on a partic-
ular lineage of cells or tissue. The protein contains an SH3
domain that would implicate it in signal transduction. The
protein also contains a domain with homology to the catalytic
domain of members of the bis-phosphoglycerate mutase family
of enzymes. However, we have been unable to demonstrate a
catalytic function for this region of p70. Members of the phos-
phoglycerate mutase family of enzymes are not known to have
protein interaction domains, such as an SH3 domain. The
function of the SH3 domain of p70 might be either to target it
to a specific molecular complex or to enable its interaction with
regulatory proteins.
One important approach to defining gene function is to
determine the consequences of eliminating the gene in the
general context of mouse development. As illustrated here, we
were able to develop a strain of mice in which the p70 gene
TABLE 1. In vitro colony formation of bone marrow hematopoietic
progenitors from wild-type and p70-deficient littermates in response
to various cytokinesa
Colony type Cytokine No. of colonies formedfrom p70 genotype
/ /
CFU-E Epo 121  9 100  13
BFU-E Epo, IL-3 27  5 25  5
CFU-G G-CSF 39  3 37  16
CFU-GM GM-CSF 27  7 33  8
CFU-Mix IL-3 43  12 41  10
CFC-Mix IL-3, IL-6, SCF, Epo 12  2 16  3
CFU-Eos IL-5 37  9 29  5
CFU-Meg Tpo 11  2 13  5
CFU-Mix SCF 32  5 37  4
Pre-B IL-7 13  4 10  2
a Bone marrow cells from four animals of each genotype were prepared for
colony assay.
FIG. 5—Continued.
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FIG. 6. Flow cytometry analysis of T and B cells. Calculated percentages are displayed within each quadrant. (A) Thymocytes from wild-type
and p70-deficient mice were stained with Cyc-conjugated anti-CD4 and FITC-conjugated anti-CD8. (B) Splenocytes from wild-type and p70-
deficient mice were stained with Cyc-conjugated anti-B220 and FITC-conjugated anti-CD3 antibodies (top pair). Alternatively, splenocytes were
stained with PE-conjugated anti-Thy1.2, Cyc-conjugated anti-CD4, and FITC-conjugated anti-CD8. The CD4/CD8 profile of splenocytes gated on
Thy 1.2-positive cells is displayed (bottom panel). (C) Splenocytes from / or / mice were stained with FITC-conjugated anti-IgD,
PE-conjugated anti-IgM, and Cyc-conjugated anti-B220. The IgM/IgD profile of splenocytes gated on B220-positive cells is displayed. Shown are
representative FACS analyses of at least six mice of each genotype.
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contained an internal deletion that resulted in a protein null
phenotype. Extensive characterization of these mice has failed
to identify any phenotypic characteristics that are different
from those of wild-type mice. Most specifically, none of the
receptor systems that utilize Jak2 that we examined were af-
fected by the absence of p70, demonstrating the lack of a
nonredundant, essential role in signaling. The absence of any
phenotypic alterations in such cases can often be attributed to
functional redundancy between family members.
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